claim: A near-Earth object is one whose orbit brings it away from Earth.
evidence: -1 - -LRB- Benzofuran-2-yl -RRB- -2 - propylaminopentane - BPAP -RRB- , BFPAPn , or BFPAP is a drug with an unusual effects profile .. drug. drug. It can loosely be grouped with the stimulant or antidepressant drug families , but its mechanism of action is quite different .. drug. drug. stimulant. stimulant. antidepressant. antidepressant. BPAP -LRB- along with another similar compound PPAP -RRB- is classified as a catecholaminergic and serotonergic activity enhancer .. PPAP. ( - )-1-phenyl-2-propylaminopentane. serotonergic. serotonergic. This means that it stimulates the impulse propagation mediated transmitter release of the neurotransmitters dopamine , norepinephrine and serotonin in the brain .. impulse. Action potential. dopamine. dopamine. norepinephrine. norepinephrine. serotonin. serotonin. However , unlike stimulant drugs like amphetamine , which release a flood of these neurotransmitters in an uncontrolled manner , BPAP instead only increases the amount of neurotransmitter that gets released when a neuron is stimulated by receiving an impulse from a neighbouring neuron .. stimulant. stimulant. impulse. Action potential. neurotransmitter. neurotransmitter. amphetamine. amphetamine. neuron. neuron. So while both amphetamine and BPAP increase the amount of neurotransmitters that get released , amphetamine causes neurons to dump neurotransmitter stores into the synapse regardless of external input , while with BPAP the pattern of neurotransmitter release is not changed , but when the neuron would normally release neurotransmitter , a larger amount than normal is released .. neurotransmitter. neurotransmitter. amphetamine. amphetamine. neuron. neuron. synapse. synapse. Other drugs which produce this effect are the endogenous trace amines phenethylamine and tryptamine , and the neuroprotective MAO-B inhibitor selegiline .. endogenous. endogenous. phenethylamine. phenethylamine. tryptamine. tryptamine. neuroprotective. neuroprotective. MAO-B. Monoamine oxidase B. inhibitor. Monoamine oxidase inhibitor. selegiline. selegiline. However , while selegiline is a potent monoamine oxidase inhibitor , BPAP is only a weak MAO-A inhibitor at high doses , and at low doses produces only the activity enhancer effect .. inhibitor. Monoamine oxidase inhibitor. selegiline. selegiline. monoamine oxidase inhibitor. monoamine oxidase inhibitor. MAO-A. Monoamine oxidase A. BPAP has been shown to have neuroprotective effects similar to those of selegiline , and has been researched for the treatment of Alzheimer 's disease , Parkinson 's disease and clinical depression .. neuroprotective. neuroprotective. selegiline. selegiline. clinical depression. clinical depression